Table 2. Incidence of cardiac events by... | American Society of Hematology

Table 2.

Incidence of cardiac events by calendar year

	Deferoxamine			Deferiprone
Year^*	No. patients at risk	No. cardiac events (% [95% CI])	No. patients at risk	No. cardiac events (% [95% CI])†
1995	516	3 (0.58 [0.12, 1.69])	0	0 (—)
1996	444	11 (2.48 [1.24, 4.39])	63	0 (0 [0, 5.69])
1997	420	4 (0.95 [0.26, 2.42])	75	0 (0 [0, 4.80])
1998	398	5 (1.26 [0.41, 2.91])	93	0 (0 [0, 3.85])
1999	396	3 (0.76 [0.16, 2.20])	89	0 (0 [0, 4.06])
2000	393	4 (1.02 [0.28, 2.59])	87	0 (0 [0, 4.15])
2001	387	6 (1.55 [0.57, 3.34])	89	0 (0 [0, 4.06])
2002	374	4 (1.07 [0.29, 2.72])	88	0 (0 [0, 4.30])
2003	358	12 (3.35 [1.74, 5.78])	92	0 (0 [0, 3.93])

	Deferoxamine			Deferiprone
Year^*	No. patients at risk	No. cardiac events (% [95% CI])	No. patients at risk	No. cardiac events (% [95% CI])†
1995	516	3 (0.58 [0.12, 1.69])	0	0 (—)
1996	444	11 (2.48 [1.24, 4.39])	63	0 (0 [0, 5.69])
1997	420	4 (0.95 [0.26, 2.42])	75	0 (0 [0, 4.80])
1998	398	5 (1.26 [0.41, 2.91])	93	0 (0 [0, 3.85])
1999	396	3 (0.76 [0.16, 2.20])	89	0 (0 [0, 4.06])
2000	393	4 (1.02 [0.28, 2.59])	87	0 (0 [0, 4.15])
2001	387	6 (1.55 [0.57, 3.34])	89	0 (0 [0, 4.06])
2002	374	4 (1.07 [0.29, 2.72])	88	0 (0 [0, 4.30])
2003	358	12 (3.35 [1.74, 5.78])	92	0 (0 [0, 3.93])

— indicates not applicable.

Each subject is included once in each year, based on the treatment received on January 1 of that year

One-sided 97.5% confidence interval